Patents by Inventor Robert Wiley

Robert Wiley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7166606
    Abstract: The compounds of formula (I) in which R represents a hydrogen atom or a fluorine atom, or a pharmaceutically acceptable salt thereof are Factor Xa inhibitors useful in the treatment of thrombotic disorders.
    Type: Grant
    Filed: March 24, 2003
    Date of Patent: January 23, 2007
    Assignee: Eli Lilly and Company
    Inventors: Michael Robert Wiley, Gary Lowell Engel
  • Patent number: 7163938
    Abstract: This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: January 16, 2007
    Assignee: Eli Lilly and Company
    Inventors: David Kent Herron, Sajan Joseph, Angela Lynn Marquart, John Joseph Masters, David Mendel, Gerald Floyd Smith, Philip Parker Waid, Michael Robert Wiley, Ying Kwong Yee
  • Patent number: 7160878
    Abstract: This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
    Type: Grant
    Filed: July 18, 2001
    Date of Patent: January 9, 2007
    Assignee: Eli Lilly and Company
    Inventors: David Kent Herron, Sajan Joseph, Angela Lynn Marquart, John Joseph Masters, David Mendel, Gerald Floyd Smith, Philip Parker Waid, Michael Robert Wiley, Ying Kwong Yee
  • Publication number: 20060263016
    Abstract: An apparatus for fusion splicing optical fibers includes an airtight enclosure, a vacuum pump for evacuating the enclosure, first and second electrodes positioned within the enclosure, and a power source separate from an external to the enclosure for applying a voltage to the first electrode for generating an arc between the electrodes that is used to splice the first and second optical fiber portions together. Also, a method of fusion splicing optical fibers includes receiving first and second fiber portions within an airtight enclosure, evacuating the airtight enclosure, and applying a voltage to a first electrode within the enclosure from a source located separate from and external to the enclosure to cause the generation of an arc between the first electrode and a second electrode within the enclosure that is used to splice the first and second optical fiber portions together.
    Type: Application
    Filed: May 18, 2006
    Publication date: November 23, 2006
    Applicant: 3SAE Technologies, Inc.
    Inventors: Robert Wiley, Donald Grasso, Steven Valle, Roberto Rivera, Jared Meitzler, Clyde Troutman
  • Patent number: 7129245
    Abstract: This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
    Type: Grant
    Filed: July 29, 2003
    Date of Patent: October 31, 2006
    Assignee: Eli Lilly and Company
    Inventors: Douglas Wade Beight, Trelia Joyce Craft, Carl Penman Denny, Jeffry Bernard Franciskovich, Theodore Goodson, Jr., Steven Edward Hall, David Kent Herron, Sajan Joseph, Valentine Joseph Klimkowski, Jeffrey Alan Kyle, John Joseph Masters, David Mendel, Guy Milot, Marta Maria Pi{hacek over (n)}elro-Nú{hacek over (n)}ez, Jason Scott Sawyer, Robert Theodore Shuman, Gerald Floyd Smith, Anne Louise Tebbe, Jennifer Marie Tinsley, Leonard Crayton Weir, James Howard Wikel, Michael Robert Wiley, Ying Kwong Yee
  • Patent number: 7127534
    Abstract: A method for managing read and write data congestion in a system for executing write and read data commands and having a buffer pool of blocks for temporarily storing read and write data is disclosed. Management of the buffer pool and the initiation of read and write commands ensures that free blocks are available to temporarily store read data arriving at a host bus adapter (HBA). If the currently available blocks would be substantially consumed by the total outstanding inbound read data requested, no more write data commands will be initiated. As inbound read data is received into the buffer pool and subsequently transferred out of the buffer pool to the initiator device, the blocks in the buffer pool are freed up. When the read data transfer is completed and sufficient buffer resources have been freed up, read and write data commands may resume.
    Type: Grant
    Filed: June 27, 2003
    Date of Patent: October 24, 2006
    Assignee: Emulex Design & Manufacturing Corporation
    Inventors: Thomas Patrick Jackson, Curtis Edward Nottberg, David Robert Wiley, Marc Timothy Jones
  • Patent number: 7115609
    Abstract: Compounds of formula (I) in which R1, R2, n and X1 have the meanings given in the specification are Factor Xa inhibitors useful in the treatment of thrombotic disorders.
    Type: Grant
    Filed: December 9, 2002
    Date of Patent: October 3, 2006
    Assignee: Eli Lilly and Company
    Inventors: Stuart Donald Jones, Daniel Jon Sall, Michael Robert Wiley
  • Patent number: 7078415
    Abstract: Compounds of formula (I) in which R, R1, R2, n and X1 have the meanings given in the specification are Factor Xa inhibitors useful in the treatment of thrombotic disorders.
    Type: Grant
    Filed: December 9, 2002
    Date of Patent: July 18, 2006
    Assignee: Eli Lilly and Company
    Inventors: Michael Robert Wiley, Daniel Jon Sall, Christopher William Murray, Stephen Clinton Young, Jolie Anne Bastian
  • Patent number: 7053078
    Abstract: Compounds of formula (I) in which R2, X, Y, Cy, L and Lp(D)n have the meanings given in the specification, are inhibitors of the serine protease, Factor Xa and are useful in the treatment of cardiovascular disorders.
    Type: Grant
    Filed: June 12, 2001
    Date of Patent: May 30, 2006
    Assignee: Eli Lilly and Company
    Inventors: John Walter Liebeschuetz, Christopher William Murray, Stephen Clinton Young, Nicholas Paul Camp, Stuart Donald Jones, William Alexander Wylie, John Joseph Masters, Michael Robert Wiley, Scott Martin Sheehan, David Birenbaum Engel, Brian Morgan Watson
  • Publication number: 20050241105
    Abstract: The present invention uses a unique slide hinge, preferably mounted to the side of the exterior door for a storage compartment in a recreational vehicle. The hinge is particularly applicable for use with a trunk door on vehicles over 5,500 pounds gross vehicle weight. Unlike the more common piano hinges, the slide hinge provided by the present invention can be staked, i.e. “mechanically retained,” in an open orientation. For example, the hinge can be held in an orientation that forms a 90° angle between the door and the body of the recreational vehicle. The hinge also presents a low profile relative to the mounting surface when the hinge is in the open orientation.
    Type: Application
    Filed: April 26, 2005
    Publication date: November 3, 2005
    Inventor: Robert Wiley
  • Patent number: 6946467
    Abstract: The compound 1-(indole-6-carbonyl-D-phenylglycinyl)-4-(1-methylpiperidin-4-yl)piperazine and physiologically-tolerable salts thereof are factor Xa inhibitors useful for the treatment of thrombotic disorders.
    Type: Grant
    Filed: December 6, 2001
    Date of Patent: September 20, 2005
    Assignee: Eli Lilly and Company
    Inventors: John Walter Liebeschuetz, Christopher William Murray, Stephen Clinton Young, Nicholas Paul Camp, Stuart Donald Jones, William Alexander Wylie, John Joseph Masters, Michael Robert Wiley, Scott Martin Sheehan, David Birenbaum Engel, Brian Morgan Watson, Peter Robert Guzzo, Michael John Mayer
  • Patent number: 6936611
    Abstract: Compounds of formula (I) in which R2, X, Y, Cy, L and Lp(D)n have the meanings given in the specification, are inhibitors of the serine protease, Factor Xa and are useful in the treatment of cardiovascular disorders.
    Type: Grant
    Filed: January 12, 2004
    Date of Patent: August 30, 2005
    Assignee: Eli Lilly and Company
    Inventors: John Walter Liebeschuetz, Christopher William Murray, Stephen Clinton Young, Nicholas Paul Camp, Stuart Donald Jones, William Alexander Wylie, John Joseph Masters, Michael Robert Wiley, Scott Martin Sheehan, David Birenbaum Engel, Brian Morgan Watson, Peter Robert Guzzo, Michael John Mayer
  • Patent number: 6924296
    Abstract: This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
    Type: Grant
    Filed: August 6, 2001
    Date of Patent: August 2, 2005
    Assignee: Eli Lilly and Company
    Inventors: Douglas Wade Beight, John Joseph Masters, Jason Scott Sawyer, Robert Theodore Shuman, Michael Robert Wiley, Ying Kwong Yee
  • Patent number: 6924439
    Abstract: The invention herein pertains to improved methods and apparatus for electrically coupling components within a digital data system without the use of ribbon cables and other wires. The disclosed coupling device comprises a body member and at least one finger member. The body member physically and electrically couples with components mounted on a circuit board by mating with component pins extending on a solder side of the circuit board. The finger member is conjoined with the body member, and is a flexible, twistable, thin member containing electrically conductive vias coupled which couple the mounted components with an electrical connected located at the distal end of the finger member. The electrical connector at the distal end of the finger member can be a solder pad, a further member body, or other electrically coupling connector device. The finger member is designed to impact cooling air flow less than the disturbances created by conventional component coupling methods and apparatus, e.g.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: August 2, 2005
    Assignee: Network Engines, Inc.
    Inventors: Christopher S. Bonni, Jerry Jarvis, Thomas Savage, James Harvey Smith, Joanne Sheehan, Robert Wiley, David Potter
  • Patent number: 6909603
    Abstract: The present invention is directed to a chassis slide assembly comprised of a mating rail and track that telescopically engage with one another and that are adapted for coupling to a chassis and to a rack to allow the chassis to be pulled out from the rack for inspection, service or repair. The rail and track each have at least one air flow aperture positioned to allow unobstructed venting of air through the slide assembly and through the side wall of the chassis. In one embodiment, the rail and track have a plurality of airflow apertures. The apertures of the rail and track can consist of a large-area openings, or of a plurality of slots or perforations. In one embodiment, the apertures of the rail are substantially aligned with the apertures of the track, e.g. when the rail and track are fully engaged with one another.
    Type: Grant
    Filed: June 23, 2003
    Date of Patent: June 21, 2005
    Assignee: Network Engines, Inc.
    Inventor: Robert Wiley
  • Patent number: 6900196
    Abstract: Compounds of formula (I) in which R2, X, Y, Cy, L and Lp(D)n have the meanings given in the specification, are inhibitors of the serine protease, Factor Xa and are useful in the treatment of cardiovascular disorders.
    Type: Grant
    Filed: July 6, 2004
    Date of Patent: May 31, 2005
    Assignee: Eli Lilly and Company
    Inventors: John Walter Liebeschuetz, Christopher William Murray, Stephen Clinton Young, Nicholas Paul Camp, Stuart Donald Jones, William Alexander Wylie, John Joseph Masters, Michael Robert Wiley, Scott Martin Sheehan, David Birenbaum Engel, Brian Morgan Watson
  • Publication number: 20050109177
    Abstract: A system and method for cleaving an optical fiber having a first end and a second end are provided, including circumferentially scoring the outer surface of the optical fiber with at least one blade and applying tension to at least the first end or the second end of the optical fiber until the optical fiber cleaves.
    Type: Application
    Filed: August 23, 2004
    Publication date: May 26, 2005
    Inventors: Robert Wiley, Brett Clark, Jared Meitzler, Roberto Rivera, Clyde Troutman
  • Patent number: 6878725
    Abstract: Compounds of formula (I) in which R2, X, Y, Cy, L and Lp(D)n have the meanings given in the specification, are inhibitors of the serine protease, Factor Xa and are useful in the treatment of cardiovascular disorders.
    Type: Grant
    Filed: June 12, 2001
    Date of Patent: April 12, 2005
    Assignee: Eli Lilly and Company
    Inventors: John Walter Liebeschuetz, Christopher William Murray, Stephen Clinton Young, Nicholas Paul Camp, Stuart Donald Jones, William Alexander Wylie, John Joseph Masters, Michael Robert Wiley, Scott Martin Sheehan, David Birenbaum Engel, Brian Morgan Watson
  • Publication number: 20050043892
    Abstract: Disclosed herein are systems and methods of hydrocarbon detection based on wavelet energy absorption analysis. One disclosed hydrocarbon detection method embodiment comprises: a) obtaining seismic trace data for a region of interest; and b) processing the seismic trace data to determine at least one wavelet energy absorption factor as a function of position within the region of interest. Another disclosed hydrocarbon detection method embodiment comprises: a) receiving from a user an indication of a region of interest in a seismic data set; and b) generating a display of wavelet energy absorption anomalies within the region of interest. One of the disclosed system embodiments comprises a memory and a processor. In this system embodiment, the memory stores hydrocarbon detection software that, when executed by the processor, configures the processor to determine at least one wavelet energy absorption factor from seismic trace data.
    Type: Application
    Filed: August 4, 2004
    Publication date: February 24, 2005
    Applicant: APEX METALINK, INC.
    Inventors: Eugene Lichman, Scott Peters, Robert Wiley
  • Patent number: 6855715
    Abstract: Compounds of formula (I) where R2, each X, L, Y, Cy, Lp, D and n are as defined in the specification, are serine protease inhibitors useful as antithrombotic agents.
    Type: Grant
    Filed: June 13, 2000
    Date of Patent: February 15, 2005
    Assignee: Eli Lilly and Company
    Inventors: John Walter Liebeschuetz, Amanda Jane Lyons, Christopher William Murray, Andrew David Rimmer, Stephen Clinton Young, Nicholas Paul Camp, Stuart Donald Jones, Phillip John Morgan, Simon James Richards, William Alexander Wylie, John Joseph Masters, Michael Robert Wiley